Advances in Ocular Drug Delivery: Emerging Technologies for the Anterior Segment
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 32
Special Issue Editors
Interests: ocular drug delivery; contact lenses; dry eye; microbial keratitis
Special Issue Information
Dear Colleagues,
The anterior segment of the eye presents unique challenges for effective drug delivery due to its protective barriers, rapid clearance mechanisms, and the need for precise targeting to treat conditions such as glaucoma, microbial keratitis, and anterior uveitis. Traditional methods like topical eye drops often suffer from poor bioavailability and patient compliance.
This Special Issue aims to explore cutting-edge technologies and strategies that are transforming anterior segment drug delivery. Topics will include novel formulations (e.g., nanoparticles), sustained-release systems, minimally invasive delivery devices, nanocarriers, and gene therapy approaches tailored for anterior segment diseases. Innovations in materials science, pharmacokinetics, and ocular surface interactions will also be covered.
We welcome original research articles, reviews, and perspectives that highlight recent advances, clinical applications, regulatory considerations, and translational challenges in the field.
Dr. Raquel Gil-Cazorla
Dr. Affiong Iyire
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ocular drug delivery
- anterior segment
- sustained-release systems
- nanotechnology
- novel delivery platforms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
